Human papillomavirus vaccination coverage among females and males, National Health and Nutrition Examination Survey, United States, 2007–2016 ()

von Lewis, Rayleen M., Markowitz, Lauri E.
Veröffentlicht in Vaccine (2018)

The Cost-effectiveness of Human Papillomavirus Vaccine Catch-up Programs for Women

von Chesson, Harrell W., Markowitz, Lauri E.
Veröffentlicht in J Infect Dis (2014)

Uptake of Human Papillomavirus Vaccine Among Adolescent Males and Females: Immunization Information System Sentinel Sites, 2009–2012

von Cullen, Karen A., Stokley, Shannon, Markowitz, Lauri E.
Veröffentlicht in Acad Pediatr (2014)

Quadrivalent HPV vaccine safety review and safety monitoring plans for nine-valent HPV vaccine in the United States

von Gee, Julianne, Weinbaum, Cindy, Sukumaran, Lakshmi, Markowitz, Lauri E.
Veröffentlicht in Hum Vaccin Immunother (2016)

Timing of HPV vaccine intervals among United States teens with consideration to the current ACIP schedule and the WHO 2-dose schedule

von Cloessner, Emily A., Stokley, Shannon, Yankey, David, Markowitz, Lauri E.
Veröffentlicht in Hum Vaccin Immunother (2015)

Human Papillomavirus Vaccination and Age at First Sexual Activity, National Health and Nutrition Examination Survey

von Petrosky, Emiko Y., Liu, Gui, Hariri, Susan, Markowitz, Lauri E.
Veröffentlicht in Clin Pediatr (Phila) (2016)

Cost-effectiveness of Human Papillomavirus Vaccination in the United States

von Chesson, Harrell W., Ekwueme, Donatus U., Saraiya, Mona, Markowitz, Lauri E.
Veröffentlicht 2008

HPV vaccine coverage among men who have sex with men – National HIV Behavioral Surveillance System, United States, 2011

von Meites, Elissa, Markowitz, Lauri E., Paz-Bailey, Gabriela, Oster, Alexandra M.
Veröffentlicht in Vaccine (2014)

Health Care Use and Opportunities for Human Papillomavirus Vaccination Among Young Men Who Have Sex With Men

von Meites, Elissa, Krishna, Nevin K., Markowitz, Lauri E., Oster, Alexandra M.
Veröffentlicht in Sex Transm Dis (2013)

Impact and Cost-effectiveness of 3 Doses of 9-Valent Human Papillomavirus (HPV) Vaccine Among US Females Previously Vaccinated With 4-Valent HPV Vaccine

von Chesson, Harrell W., Laprise, Jean-François, Brisson, Marc, Markowitz, Lauri E.
Veröffentlicht in J Infect Dis (2016)

Increasing Human Papillomavirus Vaccination at the Recommended Age

von Lin, Xia, Shrader, Lauren, Rodgers, Loren, Stokley, Shannon, Markowitz, Lauri E.
Veröffentlicht in Vaccine (2018)

The Estimated Lifetime Probability of Acquiring Human Papillomavirus in the United States

von Chesson, Harrell W., Dunne, Eileen F., Hariri, Susan, Markowitz, Lauri E.
Veröffentlicht in Sex Transm Dis (2014)

Population Impact of HPV Vaccines: Summary of Early Evidence

von Hariri, Susan, Markowitz, Lauri E., Dunne, Eileen F., Unger, Elizabeth R.
Veröffentlicht in J Adolesc Health (2013)

Seroprevalence of Herpes Simplex Virus Types 1 and 2 Among Pregnant Women and Sexually Active, Nonpregnant Women in the United States

von Patton, Monica E., Bernstein, Kyle, Liu, Gui, Zaidi, Akbar, Markowitz, Lauri E.
Veröffentlicht in Clin Infect Dis (2018)

Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007–2012, and Postlicensure Vaccine Safety Monitoring, 2006–2013 — United States

von Stokley, Shannon, Curtis, C. Robinette, Jeyarajah, Jenny, Harrington, Theresa, Gee, Julianne, Markowitz, Lauri
Veröffentlicht in MMWR Morb Mortal Wkly Rep (2013)

The impact and cost-effectiveness of nonavalent HPV vaccination in the United States: Estimates from a simplified transmission model

von Chesson, Harrell W., Markowitz, Lauri E., Hariri, Susan, Ekwueme, Donatus U., Saraiya, Mona
Veröffentlicht in Hum Vaccin Immunother (2016)

Comparison of 2-Dose and 3-Dose 9-Valent Human Papillomavirus Vaccine Schedules in the United States: A Cost-effectiveness Analysis

von Laprise, Jean-François, Markowitz, Lauri E., Chesson, Harrell W., Drolet, Mélanie, Brisson, Marc
Veröffentlicht in J Infect Dis (2016)

Human Papillomavirus Vaccination Coverage Using Two-dose or Three-dose Schedule Criteria

von Lin, Xia, Rodgers, Loren, Zhu, Liping, Stokley, Shannon, Meites, Elissa, Markowitz, Lauri E.
Veröffentlicht in Vaccine (2017)

2463. Post-licensure Surveillance of 9-Valent Human Papillomavirus Vaccine (9vHPV) in the Vaccine Adverse Event Reporting System (VAERS), United States, 2014–2017

von Arana, Jorge, Su, John, Lewis, Paige, Cano, Maria, Markowitz, Lauri E, Shimabukuro, Tom
Veröffentlicht in Open Forum Infect Dis (2018)

Cost-effectiveness of nonavalent HPV vaccination among males aged 22 through 26 years in the United States ☆

von Chesson, Harrell W., Meites, Elissa, Ekwueme, Donatus U., Saraiya, Mona, Markowitz, Lauri E.
Veröffentlicht in Vaccine (2018)